In vitro small intestinal epithelial cell growth on a nanocomposite polycaprolactone scaffold by Gupta, Ashish et al.
Biotechnol. Appl. Biochem. (2009) 54, 221–229 (Printed in Great Britain) doi:10.1042/BA20090214 221
In vitro small intestinal epithelial cell growth on a
nanocomposite polycaprolactone scaffold
Ashish Gupta∗†, Dina S. Vara∗, Geoffrey Punshon∗†, Kevin M. Sales‡,M a r cC .W i n s l e t †§ 
and Alexander M. Seifalian∗†‡§1
*Centre for Nanotechnology, Biomaterials and Tissue Engineering, University College London, London, U.K., †Gastroenterology
Research Group, UCL Division of Surgery and Interventional Science, University College London, London, U.K., ‡Stem Cells
Research Group, University College London, London, U.K., §Royal Free Hampstead NHS Trust Hospital, London, U.K., and
 University College London Hospital, London, U.K.
Tissue engineering of the small intestine remains
experimental despite worldwide attempts to develop
a functional substitute for short bowel syndrome.
Most published studies have reported predominant
use of PLLA (poly-L-lactide acid)/PGA (polyglycolic
acid) copolymer as the scaffold material, and studies
have been limited by in vivo experiments. This lack of
progress has inspired a fresh perspective and provoked
further investigation and development in this ﬁeld of
tissue engineering. In the present paper, we exploit a
relatively new nanocomposite of POSS (polyhedral oli-
gomeric silsesquioxane) and PCL [poly(caprolactone-
urea)urethane] as a material to develop porous
scaffolds using a solvent casting/particulate leaching
technique to fabricate porous scaffolds in different
pore sizes and porosities. Scaffolds were characterized
for pore morphology and porosity using scanning
electronmicroscopyandmicro-computedtomography.
Rat intestinal epithelial cells were then seeded on
to the polymer scaffolds for an in vitro study of cell
compatibility and proliferation, which was assessed
by Alamar Blue
TM and lactate dehydrogenase assays
performed for 21 days post-seeding. The results
obtained demonstrate that POSS–PCL nanocomposite
was produced as a macroporous scaffold with porosity
over the range of 40–80% and pore size over the range
of 150–250 μm. This scaffold was shown to support
epithelial cell proliferation and growth. In conclusion,
as a further step in investigating small intestinal tissue
engineering, the nanocomposite employed in this study
may prove to be a useful alternative to poly(lactic-co-
glycolic acid) in the future.
Introduction
SBS (short bowel syndrome) is a dreaded condition of
nutritional malabsorption related to the surgical removal
or disease of a large portion of the small intestine (loss
of more than 70%) [1]. Improving the nutritional status of
the patients by EN (enteral) and PN (parenteral) feeding
has been used as a life-saving treatment for patients with
intestinal failure. The high costs and high mortality [2,3]
associated with PN feeding further emphasize the need for a
moredeﬁnitivetreatmentforSBS.Attemptshavebeenmade
to treat SBS by surgical procedures like sequential intestinal
loop lengthening, but with little success [4,5]. For patients
dependent on PN feeding, intestinal transplantation remains
the most promising treatment in the present medical ﬁeld.
However, patient survival rates are poor [6,7]; there are
high incidences of rejection and limited availability of donor
organs.
There have been attempts to engineer the small
intestine since 1998 and it has the potential to be a
clinically viable option for those suffering from SBS in
the future [8]. We have highlighted the major advances
made so far in this ﬁeld [8]. The development of a
tissue-engineered intestine requires overcoming obstacles
in developing epithelial growth and differentiation on top
of a vascularized subepithelial matrix as well as developing
an innervated muscular layer. Choi and Vacanti [9] have
employed rat intestine epithelial organoid units [10] as a cell
source to be seeded on to porous synthetic biodegradable
polymer scaffolds made of PGA (polyglycolic acid) or
copolymer PLGA [poly(lactic-co-glycolic acid)] and have
achieved considerable success in regenerating neointestinal
tissue.
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Despite the demonstrated success of Choi and Vacanti
[9] in rat models, there does not appear to be a concrete
way forward for the employment of this technique in
humans. There are many questions that remain unanswered
and several difﬁculties to overcome. First, it is unclear
whether the absorptive capacity is improved through the
anastomosed segment of a tissue-engineered small intestine
because of added mucosal surface area or because of slow
transit. Secondly, the entire intestinal length of 40 neonatal
rats was required to make organoid unit-polymer constructs
sufﬁcient to implant in 10 adult rats. The question of
availability of humanneonatal intestine in suchlarge amounts
is likely to be one of the major limiting factors in developing
this procedure clinically. Finally, the immunocompatibility
is not going to be any better than the transplant
procedure.
It would appear that the entire concept of small
intestinal tissue engineering needs a fresh impetus to
progress. One ﬁeld currently of great interest in tissue
engineering is the potential use of human stem cells
[11,12]. Stem cells from peripheral blood, if they can be
cued towards intestinal lineage, could prove to be a holy
grail in the development of a successful procedure. A
betterunderstandingofcell–cellandcell–ECM(extracellular
matrix) interactions, speciﬁc stem cell markers and trophic
growth factors is required [13]. So far, only PLGA or
PGA alone has been predominantly experimented for small
intestinal tissue engineering [8]. One area in which a
fresh perspective may be achieved is by looking at other
potential scaffolds such as a relatively new biodegradable
nanocomposite developed by incorporating the biostable
POSS (polyhedral oligomeric silsesquioxane) nanocages
into a poly(caprolactone/carbonate)urethane urea [14].
Nanocomposites can be deﬁned as multiphase solid
materials where one of the phases has a dimension of
less than 100 nm [15]. POSS molecules are 6 nm in size.
Studies on the biodegradation of this polymer have been
carried out previously [14]. These studies showed that the
incorporation of POSS nanocomposites into the poly-
(caprolactone/carbonate)urethane/urea resulted in the
development of a degradable polymer that preserves its
mechanical properties as it undergoes oxidation, hydrolysis
or degradation by plasma protein fractions [16]. The
nanocages provide a ‘shielding effect’ on the soft phase
of the polymer. PCL (polycaprolactone) is a degradable
aliphatic polyester that has been extensively reported to
demonstrate biocompatibility in vivo. Its degradation by
hydrolysis and enzymes is well documented. PCL has
been used in several copolymers and polymer blends as
the foundation for a tailor-made polymer with speciﬁc
properties. The in vivo host response of POSS–PCL has
not been studied; however, POSS–PCU [poly(carbonate-
urea)urethane], the non-biodegradable counterpart lacking
PCL, made by the same group, was implanted in sheep for 36
months and showed only minimal inﬂammation as compared
with silicone implants [17]. It is proposed that caprolactone
will provide controlled degradation, whereas the POSS
nanocages will contribute to the mechanical strength
required for a tissue engineering scaffold for soft tissue
such as the small intestine. Our laboratory is investigating
individually the two main components involved in small
intestinal tissue engineering: scaffolds using nanocomposite
(POSS–PCL) developed and patented by our group [18],
and in another simultaneous study, trying to extract stem
cells from peripheral blood and co-culturing them with
intestinal myoﬁbroblasts in order to differentiate them
into IECs (intestinal epithelial cells). The present paper
describes our studies on the nanocomposite biodegradable
polymer scaffold fabricated by us, examining its preparation,
characterization, mechanical testing and in vitro cell culture
results using a rat IEC cell line in order to optimize the
scaffold conditions most suitable for small intestinal tissue
engineering.
Materials and methods
Preparation of the polymer (POSS–PCL)
Dry polyol blend [80% (w/w) polycaprolactone diol and
20% (w/w) polycarbonate diol; Mr 2000] and trans-
cyclohexanediolisobutyl-POSS were placed in a reaction
ﬂask equipped with a mechanical stirrer and a gas inlet.
The mixture was heated to dissolve the POSS cage into the
polyol and then cooled. Subsequently, ﬂake MDI (methylene
diphenyl isocyanate) was added to the polyol blend and
then made to react, under nitrogen, to form a prepolymer.
Dry DMAC (dimethylacetamide) was added slowly to the
prepolymer to form a solution, which was cooled to 40◦C.
Chain extension of the prepolymer was carried out by
dropwise addition of a mixture of ethylenediamine and
diethylamine to dry DMAC. After completion of the chain
extension, 1-butanol in DMAC was added to the polymer
solution to form a 20% POSS–PCL solution. All chemicals
and reagents were purchased from Sigma–Aldrich.
Characterization of the polymer
The surface tension, viscosity and electrical conductivity
of the polymer were measured. Surface tension was
measured using a Kr¨ uss Tensiometer K9 (Du Novy’s ring
6 method). Viscosity was estimated using a Bohlin CVO
rheometer (Malvern Instruments). Electrical conductivity
was assessed using a Hach SensION Tm 156 probe. All
measurements were performed at the ambient temperature
and all instruments were calibrated before use.
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Preparation of scaffolds using particulate leaching
and solvent casting
Two pore size ranges of 150–250 μm (macroporous) and
<100 μm (microporous) were used in the present study.
Dried NaCl was sieved in the desired pore size range
using stainless steel sieves (Fisher Scientiﬁc). In total, 10%
(w/v) POSS–PCL in DMAC was used in all experiments.
Two different salt concentrations, namely 40 and 80%
(w/v), in polymer were used for both macroporous and
microporous salt sizes. Both salt sizes were mixed in one
of the samples to obtain a mixed-pore-sized sample. A
control sample was prepared without any salt in it. Salt
was mixed in the polymer solution using a homogenizer
(Ultra-Turrax T25; IKA Labortechnik) and then poured over
the stainless steel plates to spread. The mixture was left in
the oven at 50◦C for 20 h. The sheets of polymer were
peeled off the plates and kept in deionized water for 72 h
with a regular change of water at 4 h intervals. After
72 h the polymer sheets were air-dried and specimens from
the samples were studied for their physical and chemical
properties.
Porosity
The porosity of the scaffolds was calculated by using
simple formulae as given below (eqn 1, eqn 2) and was
compared for its accuracy with the porosity measured
by X-ray microtopography [micro-CT (micro-computed
tomography)] in one of the samples:
P = 1 −
d
dP
where P is the porosity of the scaffold sample, d is the
densityofthescaffoldsanddp isthedensityofthenonporous
polymer. The density of the scaffold, d, can be calculated
from:
d =
m
v
where m is the mass and v is the volume of the scaffold (see
Table 1).
Table 1 Physical properties of the polymer and the organic solvent
The values are means+ −S.D. (n=3).
Surface tension Electrical conductivity Viscosity
Sample (mN/m) (10
−4 S/m) (mPa · s)
DMAC 36.0+ −0.4 0.20+ −0.01 2.20+ −0.12
POSS–PCL 48.0+ −0.3 1.70+ −0.10 9720+ −120
SEM (scanning electron microscopy)
The samples were attached to aluminium stubs with double-
sided sticky tabs and then coated with gold using an
SC500 (EMScope) sputter coater before being examined
and photographed using a Philips 501 scanning electron
microscope at 15 kV. SEM was also carried out after 21 days
of in vitro cell culture.
Micro-CT (X-ray microtomography)
In the present study, the pore morphology was mainly
studied by SEM and the porosity was calculated by
using the formula mentioned above; however, for one
sample (sample 1), the porosity and pore size of the
scaffolds were also investigated by X-ray microtomography,
in order to validate the results. The porous scaffold
sample was examined using a SkyScan-1072 high-resolution
desktop X-ray microtomography system (Skyscan). The
X-ray radiographs were collected at 20 kV/120 μAw i t h
a 0.5 mm Al ﬁlter, an 8 μm pixel size, 0.23◦ angle step
(0–180◦ rotation) and 3 frame averages per acquired
radiograph. A cone-beam accusation was selected and
cone-beam volumetric reconstruction (Feldkamp algorithm)
was employed for image reconstruction. During the image
reconstruction process, the beam hardening correction
parameter was set to 20–30%, depending on the individual
sample. Each original reconstructed image contained
1024×1024 pixels. The porosity and pore size were
calculated and analysed using CTAn software (SkyScan) as
the mean value of 100 sections studied.
Mechanical properties
Mechanical tests were performed in uniaxial tension
on a ZWICK BDO-FB.5TS tester (Ulm) unit at room
temperature (20+ −1◦C). Specimens in the form of ﬂat
dumbbells with a 40-mm-long working part were loaded
at a constant tension rate of 100 mm/min. The thickness
of samples was measured using a digital electronic outside
micrometer (UKAS Calibration) at three places of the
dumbbell and averaged. Stress–strain relationships were
obtained for the samples and graphs were plotted (Figure 1).
FTIR (Fourier-transform infrared) spectroscopy
Infrared spectra of porous (sample 1) and non-porous
(sample 5) scaffolds were recorded on a PerkinElmer
1750 FTIR spectrometer equipped with a triglycine sulfate
detector.Spectralresultswereacquiredfroma10 μlvolume
gas-tight CaF2 cell (path length 6 μm) and the temperature
of recorded spectra was 25◦C. A sample shuttle was
employed to permit the sample to be signal-averaged with
the background. For each sample, 200 scans were signal-
averaged at a resolution of 4 cm
−1.
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Figure 1 Graph presenting the stress–strain relationships for POSS–PCL
scaffold samples 1–6
Sample 5 is the non-porous sample (control). The results are mean values
(n=3) for the salt concentrations of 40 and 80% (w/v).
Polymer preparation for cell seeding
Polymer sheets of samples 1–6 were cast as above and
thoroughly washed in distilled water. Eight circular discs of
15 mm diameter per sample were then cut using a metal die.
Discs were then autoclaved to sterilize them.
Cell seeding of polymer samples
Discs of polymer samples 1–6 (n=6) prepared as above
were placed in a 24-well plate (BD Biosciences) and
seeded with rat small intestine epithelial cells [IEC 6
cell line; European Collection of Animal Cell Cultures]
at a concentration of 2.5×10
6 cells per well in 1 ml of
cell culture medium [Dulbecco’s modiﬁed Eagle’s medium
supplementedwith0.1IU/mlinsulinand5%(v/v)fetalbovine
serum plus penicillin at 100 units/ml and streptomycin at
10 μg/ml (Invitrogen)]. Tissue culture plastic wells with no
polymer were seeded with an identical amount of cells as
a positive control. Wells with polymer but no cells were
employed as a negative control. Cells were allowed to attach
for 24 h after which the medium containing unattached cells
was removed for LDH (lactate dehydrogenase) analysis to
assess initial cell damage. The seeded polymer discs were
then transferred to a fresh 24-well plate (to avoid the
possibility of measuring cells seeded on to the initial well
bottom during the seeding process) and cell metabolism
was assessed using an Alamar Blue
TM assay. Cell meta-
bolism was then further measured on days 3, 6, 10, 14 and
21 post initial seeding. Samples of seeded polymer were also
taken for analysis by SEM on day 21 as above.
Assessment of initial cell damage by LDH analysis
LDH was measured using a CytoTox 96® Non-Radioactive
Cytotoxicity Assay kit (Promega). LDH is a stable cytosolic
enzyme released on cell lysis into the cell culture medium.
The amount of LDH released is measured using a 30 min
coupled enzymatic assay based on the conversion of
a tetrazolium salt INT (2-p-iodophenyl-3-p-nitrophenyl-5-
phenyltetrazolium chloride) into a red formazin product,
with the amount of colour formed being proportional to
the number of lysed cells. A 50 μl portion of the cell culture
medium from each sample was transferred to a 96-well
plate (Helena Biosciences). A 50 μl portion of Substrate
Mix (1 vial of substrate plus 12 ml of assay buffer; Promega)
was added to each well and the plate was covered in
a foil to prevent exposure to light. Samples were then
incubated at room temperature for 30 min after which
the reaction was stopped by the addition of 50 μlo fs t o p
solution (1 M acetic acid). Attenuance (D) was then read at
450 nm using a Multiscan MS UV–visible spectrophotometer
(Labsystems).
Assessment of cell growth and metabolism by the
Alamar Blue
TM assay
AlamarBlue
TM (Serotec)isacommerciallyavailableassaythat
aims to measure quantitatively cell proliferation, cytotoxicity
and viability. This is achieved by incorporating resazurin and
resarfurin as colorimetric oxidation reduction indicators.
These indicators respond to chemical reduction resulting
from cell metabolism by changing colour. This colour change
may be measured by monitoring ﬂuorescence (λex =530 nm
and λem =620 nm). The advantages of this assay are that it is
soluble in media, stable in solution, minimally toxic to cells
and produces changes that are easily monitored.
Alamar Blue
TM was added to the cell culture medium at
a concentration of 10% (v/v). At each time point, polymer
samples were washed with 1 ml of PBS and transferred to
a fresh 24-well plate to prevent the possibility of measuring
cells growing on the bottom of the plate. A 0.5 ml portion
of the Alamar Blue
TM/cell culture medium mixture was then
addedtoeachsampleandthepositivecontrolwells.A0.5 ml
portion of the mixture was added into each of the nega-
tive control samples. After 4 h, a 100 μl sample of the
mixture was removed and the attenuance at ﬂuorescence
(λex =530 nm and λem =620 nm) was measured in a 96-well
plate (Helena Biosciences) using a Fluoroscan Ascent FL
spectrophotometer (Thermo Labsystems). The remaining
mixture was then removed and replaced with fresh cell
culture medium to continue the culture of the cells.
Statistical analysis
Statistical analysis of the results was performed using
GraphPad Prism version 5 software. The groups were
analysed for statistical signiﬁcance by one- or two-
way ANOVA tests. P<0.05 was considered statistically
signiﬁcant.
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Table2 PreparationofmacroporousandmicroporousPOSS–PCLscaffolds
using varying salt concentrations
Sample 5 (control) is the sample with no salt. Porosity values are means+ −S.D.
(n=3). –, not determined.
Concentration NaCl
of NaCl (w/v) particle size Porosity
Sample in the polymer (%) (μm) obtained (%)
1 80 150–250 83.9+ −0.5
2 40 150–250 59.5+ −0.9
38 0 <100 74.6+ −0.4
44 0 <100 61.9+ −0.3
5– – 5 . 4 + −6.0
68 0 <100 and 150–250 75.3+ −0.3
Results
Scaffold fabrication
Table 1 presents the physical properties of the POSS–
PCL polymer used in this study. Table 2 shows the
varying porosities obtained when salt was used in different
concentrations and different particle sizes. The porosity
obtained, shown in Table 2, was calculated using the simple
formulae given in the Materials and methods section (eqn 1,
eqn 2).
Figure 2 shows the SEM image of an 80% porous
scaffold (sample 1) made of POSS–PCL, showing pore size
over the range of 150–250 μm and pore interconnectivity.
The results of micro-CT (Figure 3) conﬁrmed the porosity
calculated by using simple formulae. As a mean value from
100 sections of the sample, the porosity for sample 1 was
found to be 80%+ −2%, and the pore size varied from 140
Figure 2 SEM of an 80% porous scaffold (sample 1) made of POSS–PCL,
showing pore sizes in the range 150–250 μm and pore interconnectivity
Scale bar, 500 μM.
to 250 μm, as expected from the polymer/salt ratios. Good
pore interconnectivity was seen in the sample studied.
Characterization of scaffold samples
Stress–strain patterns of scaffold samples are shown in
Figure 1. Porous scaffolds (samples 1, 2, 3, 4 and 6) are
signiﬁcantly less stiff as compared with the non-porous scaf-
fold (sample 5); P<0.05. As expected, the porous scaffolds
were less strong than the non-porous scaffold; however,
among the porous scaffolds with different porosities and
pore sizes, there was no signiﬁcant difference observed
Figure 3 Micro-CT images of the tubular scaffold of sample 1
(a) Sagittal section and (b) cross section. Pore interconnectivity can be seen in both sections. The outer thick white line is an artefact from the tape used to secure
the sample while processing for micro-CT. Pores are shown in black, whereas the polymer and a small amount of the salt remaining are shown in white.
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Figure 4 FTIR of the porous sample (sample 1) and the non-porous sample (control), essentially showing the preservation of the basic structure of the
scaffold after particulate leaching
Figure 5 LDH assay test performed on IECs seeded on POSS–PCL samples
for 24 h
Attenuance was measured in arbitrary units at 450 nm wavelength. Results are
means+ −S.E.M. (n=3). P1–P6 are the seeded discs of polymer samples 1–6.
‘Positive’ indicates the sample with an equal number of cells seeded on the
tissue culture plate without the polymer discs, serving as a positive control.
(P>0.05). FTIR was performed as a characterization tool on
a porous (sample 1) and a non-porous (sample 5) scaffold in
order to conﬁrm the preservation of the original structure
of the polymer after the processing was performed in the
form of solvent casting/particulate leaching (Figure 4).
Assessment of initial cell damage by LDH analysis
LDH release was examined to look at potential cell damage
intheinitialseedingperiod.ThedifferencesinLDHlevelsare
actually quite small compared with the levels from the tissue
culture plastic seeded cells, indicating that little initial cell
damage has occurred. When statistical analysis was carried
outonthelevelsforthescaffoldsamples,therewasinfactno
Figure 6 Alamar Blue
TM cell viability assay test on IECs seeded on POSS–
PCL samples over 21 days
Results are means+ −S.E.M. (n=6). P1–P6 are discs of polymer samples 1–6.
‘TCP control’ indicates the tissue culture plate control.
signiﬁcant difference (P>0.05) between any of the scaffold
samples (Figure 5).
Assessment of cell growth and metabolism by the
Alamar Blue
TM assay
The results obtained from the investigation of cell growth
and metabolism of IECs seeded on the various polymer
samples show an increase in cell growth and metabolism
over the course of the 21-day study (Figure 6). When
seeded on tissue culture plastic, cells reached conﬂuence
by day 10 (Figure 6, TCP control). All polymer samples
showedasigniﬁcantreductionincellgrowthandmetabolism
when compared with the positive control; P<0.05 (as
anticipated, tissue culture plastic being optimal for cell
growth). However, cell growth occurred on each polymer
sample over the whole 21 day period, suggesting a lower
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Figure 7 IECs seeded on the nanocomposite (POSS–PCL) on day 21
Scale bar, 250 μm. P1–P6 are polymer samples 1–6.
growth rate when compared with tissue culture plastic.
There was no signiﬁcant difference between any of the
polymers examined over the time period investigated
(P>0.05).
Assessment of cell seeding by SEM
The results obtained from SEM examination of seeded
polymer samples at day 21 show that cells were present on
all the polymers examined and conﬁrm the ﬁndings of the
cell growth and metabolism study (Figure 7). The cell lay-
ers are also seen to grow within the pores, suggesting cell
in-growth (Figure 8).
Discussion
Tissue engineering is based on the utilization of cells and bio-
materials. An ideal scaffold should be highly porous, and
biocompatible with a controlled degradation rate; should
have an appropriate surface for cell adhesion, proliferation
and differentiation; and should maintain proper mechanical
properties.
Our laboratory has already demonstrated the advant-
ages and the successful applications of silica nanocomposite-
basedpolyurethanesinproducingvasculartissue-engineered
grafts, such as improved cell adhesion characteristics
using a silicon pendant nanocage [19]. In the present
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Figure 8 The cell layer is seen to encroach into the pore from the surface, suggesting cell in-growth
Scale bar, 250 μm.
study, we assessed whether similar, although biodegradable,
nanocomposite POSS–PCL was safe and compatible with in
vitro cell cultures when IECs were employed. As this was
intended as a study of cytocompatibility, it was felt that it
was reasonable to use a rat intestinal cell line rather than
employ primary rat intestinal cells for which a large number
of rats would have been required to obtain an adequate
number of cells for the study. Another aim of this study
was to investigate the suitability of alternative biodegradable
polymers like POSS–PCL for soft tissue engineering, as
opposed to the widely accepted sole use of PGA/PLLA
(poly-L-lactide acid) copolymers in small intestinal tissue
engineering. PCL has the potential advantages of being less
expensive and dissolves more readily in commonly available
organic solvents when compared with PGA (which is very
hard in consistency and requires the use of highly ﬂuorinated
solvents such as hexaﬂuoroisopropanol).
The nanocomposite fabricated by us maintains
mechanical stability due to the presence of nanocages while
simultaneously allowing controlled degradation. The present
study employedtwo different pore size ranges (150–250 μm
and <100 μm) and investigated two porosities (one over
the range of 80% and the other over the range of 40%).
By utilizing solvent casting and salt leaching, production of
scaffolds with pore size and porosity in the desired range
was successfully achieved. The pores were interconnected
as can be seen from SEM and micro-CT. The mechanical
properties as well as the suitability of cell growth on the
scaffolds produced were then examined. When tested for
stress–strain relationships the results obtained show that
the strength of the scaffold decreases with an increase in
porosity.
In the present study, the approximate cell size of the
IECs was much smaller than the organoid unit employed
in the previously mentioned rat studies. IEC proliferation
was followed for 21 days on scaffolds made of high and low
porosities and large and small pore sizes. All the samples
examined were able to support both initial cell seeding
and prolonged cell growth over the course of the 21 days
investigated. In our preliminary experiments, as the scaffold
had not been washed adequately, they failed to show any
cell attachment or growth (results not shown). The washing
regime was initially to just rinse the scaffolds in deionized
water. This was then made more stringent by rinsing the
scaffolds for 72 h on a shaker with changes of water every
4 h. It is believed that DMAC or the residual salt levels used
in scaffold preparation could be cytotoxic if not removed
completely. Studies of LDH levels showed that there was
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little initial cell damage. There was no signiﬁcant difference
in cell seeding or growth between any of the samples
investigated. These ﬁndings were conﬁrmed by the SEM
studies, which showed that cells were present in all samples
on day 21. The potential of the POSS–PCL scaffold to
support cell seeding and growth was therefore conﬁrmed.
Conclusion
In the present study, a simple and inexpensive method
of solvent casting and particulate leaching was employed
to fabricate porous scaffolds using a newly developed
nanocomposite of silsesquixane-based PCL (POSS–PCL).
We showed that these scaffolds carry physical and chemical
properties for intestinal cells to remain viable within the
culture medium exposed to POSS–PCL, adhere to the poly-
mer surface, remain viable and achieve conﬂuence on the
scaffold. This in vitro study for tissue engineering of the small
intestine provides the option of using an alternative polymer
totheconventionallyusedPGAorpolylactide.Theporesize
and porosity of scaffolds should be tailor-made depending on
t h et y p ea n ds i z eo ft h ec e l ls o u r c e .
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